New research shows three in 10 cancer patients have experienced disruption to their NHS cancer treatments as a result of Covid-19.
The survey conducted by Cancer Research UK found that 900 cancer patients were surveyed between December 2020 and March 2021. Of those asked, 29% experienced delays, cancellations or changes to their treatment. Cancer Research UK labelled the impact of the pandemic on cancer services and patients as "devastating" and uncovered that opinions of NHS care have fallen since the onset of the pandemic. More than eight in 10 (84%) had recalled their care as being ‘very good' pre-pandemic. However, almost three in 10 (31%) have subsequently downgraded their rating since the start ...
To continue reading this article...
Join COVER for free
- Unlimited access to real-time news, key trend analysis and industry insights.
- Stay on top of the latest developments around health and wellbeing, diversity and inclusion and the cost of living crisis.
- Receive breaking news stories straight to your inbox in the daily newsletter.
- Members only access to monthly programme 'The COVER Review'
- Be the first to hear about our CPD accredited events and awards programmes.